PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Ascariasis D001196 3 associated lipids
Thyroid Diseases D013959 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Erythema D004890 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Hyperlipidemias D006949 73 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Hall TJ et al. Decreased natural killer cell activity in atopic eczema. 1985 Immunology pmid:3876984
Narumiya S and Toda N Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. 1985 Br. J. Pharmacol. pmid:2992661
Bertelé V et al. Refractoriness of platelets to prostaglandins after infusion in rabbits. 1985 J. Lab. Clin. Med. pmid:2997353
Thompson NT and Scrutton MC Intracellular calcium fluxes in human platelets. 1985 Eur. J. Biochem. pmid:3918866
Watanabe K et al. Biosynthesis of prostaglandin F2 alpha from prostaglandins H2 and D2 by an apparently homogeneous enzyme. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936081
Liston TE et al. Prostaglandin D2 is metabolized in humans to 9 alpha,11 beta-prostaglandin F2, a novel biologically active prostaglandin. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936123
Kimura H et al. Modulatory effects of prostaglandin D2, E2 and F2 alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro. 1985 Brain Res. pmid:2859088
Toda N et al. Neuroeffector actions of prostaglandins on isolated arteries. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936153
Ueno R et al. Prostaglandin D2: a cerebral sleep-regulating substance in rats. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936173
Urade Y et al. Purification and characterization of rat brain prostaglandin D synthetase. 1985 J. Biol. Chem. pmid:3930495
Schick B and Austen KF Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1985 Immunology pmid:3935569
Fitscha P et al. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. 1985 Am. J. Hematol. pmid:3885723
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Cutler LS et al. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2. 1985 Biochim. Biophys. Acta pmid:3890960
Siegl PK and Wenger HC Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. 1985 Eur. J. Pharmacol. pmid:3899681
Regulatory control and standardization of allergenic extracts. Clinical studies with "standardized" extracts. 1985 Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M pmid:3901924
Kiyomiya K and Oh-ishi S Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. 1985 Jpn. J. Pharmacol. pmid:3936958
Campbell WB and Gomez-Sanchez CE Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells. 1985 Endocrinology pmid:3924581
Majewska MD and Chuang DM Benzodiazepines enhance the muscimol-dependent activation of phospholipase A2 in glioma C6 cells. 1985 J. Pharmacol. Exp. Ther. pmid:2857784
Forman MB et al. Increased adventitial mast cells in a patient with coronary spasm. 1985 N. Engl. J. Med. pmid:2413358
Togias AG et al. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. 1985 J. Clin. Invest. pmid:2414318
Robin JL et al. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. 1985 J. Immunol. pmid:3161947
Schulman ES and Anderson CL Lung hypersensitivity responses: dissociation of human lung mast cell leukotriene C4 (LTC4) from histamine release. 1985 Prog. Clin. Biol. Res. pmid:2415994
Creticos PS et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. 1985 J. Clin. Invest. pmid:2416777
Holgate ST et al. The release and role of inflammatory mediators in asthma. 1985 Clin Immunol Rev pmid:2417772
Beatty CH et al. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis. 1985 Atherosclerosis pmid:3924062
Baud L et al. Lipoxygenase products mediate the attachment of rat macrophages to glomeruli in vitro. 1985 Kidney Int. pmid:3927056
Naclerio RM et al. Inflammatory mediators in late antigen-induced rhinitis. 1985 N. Engl. J. Med. pmid:2582257
Westcott JY and Murphy RC Effect of alcohols on arachidonic acid metabolism in murine mastocytoma cells and human polymorphonuclear leukocytes. 1985 Biochim. Biophys. Acta pmid:2982416
Seregi A et al. The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. 1985 Brain Res. pmid:3859353
Ikai K et al. Effect of ultraviolet irradiation on mast cell-deficient W/Wv mice. 1985 J. Invest. Dermatol. pmid:3859552
Arisawa M et al. Suppressive effect of prostaglandin D2 on prolactin secretion from rat anterior pituitary. 1985 Asia Oceania J Obstet Gynaecol pmid:3860198
Spannhake EW et al. Influence of mediators of anaphylaxis on collateral ventilation and the lung periphery of the dog. 1985 J. Pharmacol. Exp. Ther. pmid:3860642
Liston TE and Roberts LJ Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. 1985 Proc. Natl. Acad. Sci. U.S.A. pmid:3862115
Tanaka H et al. The effects of PGD2 and 9-deoxy-delta 9-PGD2 on colony formation of murine osteosarcoma cells. 1985 Prostaglandins pmid:3863195
Liston TE and Roberts LJ Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. 1985 J. Biol. Chem. pmid:3863815
Knepel W et al. Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro. 1985 J. Endocrinol. pmid:3160802
Roberts LJ and Sweetman BJ Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis. 1985 Prostaglandins pmid:3864190
Nielsen JA and Sparber SB Central administration of prostaglandin E2 facilitates while F2 alpha attenuates acute dependence upon morphine rats. 1985 Pharmacol. Biochem. Behav. pmid:3860881
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Mendieta CF et al. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. 1985 J. Periodontol. pmid:3919173
Robinson C and Holgate ST Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. 1985 Clin. Sci. pmid:2981650
Pugliese G et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. 1985 J. Biol. Chem. pmid:3863819
Bhattacharya SK and Parmar SS Prostaglandin D2-induced potentiation of hexobarbitone hypnosis in rats: role of 5-hydroxytryptamine. 1985 J. Pharm. Pharmacol. pmid:2868104
Whittle BJ et al. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets. 1985 Adv. Exp. Med. Biol. pmid:2871707
Gay SW and Kosher RA Prostaglandin synthesis during the course of limb cartilage differentiation in vitro. 1985 J Embryol Exp Morphol pmid:3867724
Hollingsworth EB and Patrick GA Involvement of the serotonergic system in the prolongation of pentobarbital sleeping time produced by prostaglandin D2. 1985 Pharmacol. Biochem. Behav. pmid:2859604
Nolan PN et al. Participation of prostanoids in chemical activation of the pericardial pressor reflex in dogs. 1985 Jan-Feb Clin. Exp. Pharmacol. Physiol. pmid:3924453
Korbut R and Gryglewski RJ Anti-aggregatory prostanoids. Part I. 1985 Sep-Dec Acta Physiol Pol pmid:3915631
Holgate ST The role of mast cells in the pathogenesis of asthma. 1985 Sep-Oct Bull Eur Physiopathol Respir pmid:2415192
Schleimer RP et al. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. 1986 J. Immunol. pmid:3082976
Barnea A et al. Evidence that a short-lived effect of copper leads to amplification of prostaglandin E2 stimulation of the release of gonadotropin-releasing hormone from median eminence explants. 1986 Endocrinology pmid:3525128
Viganò T et al. Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma "in vitro". 1986 Prostaglandins Leukot Med pmid:3020580
Burrall B and Ziboh VA Increased biosynthesis of lipoxygenase products by UVB-irradiated guinea pig epidermis: evidence of a cyclooxygenase inhibitor. 1986 J. Invest. Dermatol. pmid:3086462
Koshihara Y and Kawamura M Inhibitory effect of prostaglandin D2 on DNA synthesis in nuclei. 1986 Prostaglandins Leukot Med pmid:3020589
Jaschonek K et al. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors. 1986 Prostaglandins Leukot Med pmid:3020591
Inokuchi A and Oomura Y Effects of prostaglandin D2 on the activity of hypothalamic neurons in the rat. 1986 Jpn. J. Physiol. pmid:3022048
Saito H et al. Bio-synthesis of PGD2 and TXB2 by rabbit blood monocytes. 1986 Prostaglandins pmid:3086936
Hickok NJ et al. Characterization of prostaglandin endoperoxide synthase from a human cell line. 1986 Biochim. Biophys. Acta pmid:3087430
Ohno K et al. Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition. 1986 Biochem. Biophys. Res. Commun. pmid:3464277
MacIntyre DE et al. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators. 1986 Agents Actions Suppl. pmid:3028106
Tanaka A et al. Antiherpetic action of prostaglandin D2. 1986 Prostaglandins Leukot Med pmid:3029784
Suzuki H et al. [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2]. 1986 Nihon Naibunpi Gakkai Zasshi pmid:3465609
Kleeberger SR et al. Central role of cyclooxygenase in the response of canine peripheral airways to antigen. 1986 J. Appl. Physiol. pmid:2430928
Wells E et al. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. 1986 J. Immunol. pmid:2431049
Ashby B Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes. 1986 J Cyclic Nucleotide Protein Phosphor Res pmid:2432105
Koro O et al. Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. 1986 Br. J. Dermatol. pmid:2432916
Watanabe K [PGF synthetase]. 1986 Seikagaku pmid:3084680
Blomgren H et al. Prostaglandin sensitivity of the PHA-response of blood lymphocytes following radiation therapy for breast cancer. 1986 Radiother Oncol pmid:3466235
Kriseman T et al. Analysis of airway responses to A23187 in the cat. 1986 J. Pharmacol. Exp. Ther. pmid:3095538
Shimizu Y et al. Cycloheximide reduces PGD2 or delta 12-PGJ2 cytotoxicity on NCG cells. 1986 Prostaglandins pmid:3099333
Narumiya S and Fukushima M Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. 1986 J. Pharmacol. Exp. Ther. pmid:3772804
Narumiya S et al. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. 1986 J. Pharmacol. Exp. Ther. pmid:3772805
Bregman MD et al. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. 1986 Cancer Res. pmid:3698005
Kato T et al. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo. 1986 Cancer Res. pmid:3708585
Keeting PE et al. Rat lens prostaglandin biosynthesis during galactose-induced cataractogenesis. 1986 Exp. Eye Res. pmid:3028846
Horiguchi S et al. Alterations in nociception after intracisternal administration of prostaglandin D2, E2 or F2 alpha to conscious mice. 1986 Eur. J. Pharmacol. pmid:3458588
Zavoico GB et al. Regulation of intracellular pH in human platelets. Effects of thrombin, A23187, and ionomycin and evidence for activation of Na+/H+ exchange and its inhibition by amiloride analogs. 1986 J. Biol. Chem. pmid:3020026
Watanabe K et al. Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3456602
Maclouf J et al. Development of a radioimmunoassay for prostaglandin D2 using an antiserum against 11-methoxime prostaglandin D2. 1986 Prostaglandins pmid:3456623
Barnes VF and Heavey DJ Effect of prostaglandin D2 on histamine-induced weals in human skin. 1986 Br. J. Pharmacol. pmid:3456816
Gaetani P et al. Prostaglandin D2 monitoring in human CSF after subarachnoid hemorrhage: the possible role of prostaglandin D2 in the genesis of cerebral vasospasm. 1986 Ital J Neurol Sci pmid:3456998
Sugiyama T et al. Platelet prostaglandin D2 dehydrogenase in patients with myeloproliferative disorders. 1986 Prostaglandins Leukot Med pmid:3457389
Omini C et al. Prostaglandin D2 (PGD2) potentiates cholinergic responsiveness in guinea-pig trachea. 1986 J Auton Pharmacol pmid:3464602
Kikuchi Y et al. Inhibition of human ovarian cancer cell growth in vitro and in nude mice by prostaglandin D2. 1986 Cancer Res. pmid:3458525
Hamilton RG et al. Dirofilaria immitis: diethylcarbamazine-induced anaphylactoid reactions in infected dogs. 1986 Exp. Parasitol. pmid:3458592
Nakagawa Y et al. [Effect of prostaglandin D2 on the growth of mouse glioma]. 1986 Gan To Kagaku Ryoho pmid:3459395
Naclerio R et al. The role of inflammatory mediators in allergic rhinitis. 1986 Ear Nose Throat J pmid:3459645
Wogensen L and Warberg J Effect of prostaglandin D2 on the release of luteinizing hormone and prolactin in castrated and intact male rats. 1986 Acta Endocrinol. pmid:3461657
Murray JJ et al. Release of prostaglandin D2 into human airways during acute antigen challenge. 1986 N. Engl. J. Med. pmid:3462506
Honda C and Tabuchi K [Effects of prostaglandin D2 on cultured glioma cells]. 1986 Gan To Kagaku Ryoho pmid:3463248
Nelson CA and Seamon KB Binding of [3H]forskolin to human platelet membranes. Regulation by guanyl-5'-yl imidodiphosphate, NaF, and prostaglandins E1 and D2. 1986 J. Biol. Chem. pmid:3463564
Black JL et al. A comparison of the contractile activity of PGD2 and PGF2 alpha on human isolated bronchus. 1986 Prostaglandins pmid:3464041
Sago T et al. Metabolism of prostaglandins D2 and F2 alpha in primary cultures of rat hepatocytes. 1986 Biochim. Biophys. Acta pmid:3465372
Suzuki F et al. Transport of prostaglandin D2 into brain. 1986 Brain Res. pmid:3465420
Makhoul RG and Gewertz BL Renal prostaglandins. 1986 J. Surg. Res. pmid:3511324
Dutta-Roy AK et al. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets. 1986 Science pmid:3001935
Kashani IA et al. Effects of prostaglandins on the pulmonary vascular bed of newborn rats with chronic hypoxia. 1986 Angiology pmid:3511774
Fuller RW et al. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. 1986 Am. Rev. Respir. Dis. pmid:3511806
Blockmans D et al. Heparin-induced thrombocytopenia platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities. 1986 Thromb. Haemost. pmid:3518134